C4X Discovery (LON:C4XD) Stock Price Passes Below 50-Day Moving Average of $11.57

C4X Discovery Holdings plc (LON:C4XDGet Free Report)’s share price crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 11.57 ($0.15) and traded as low as GBX 8.30 ($0.10). C4X Discovery shares last traded at GBX 12 ($0.15), with a volume of 3,770,459 shares changing hands.

C4X Discovery Trading Up 27.3 %

The company has a debt-to-equity ratio of 1.05, a current ratio of 15.31 and a quick ratio of 9.82. The stock has a market cap of £30.27 million, a PE ratio of 300.00 and a beta of 0.23. The stock has a 50-day moving average price of GBX 11.60 and a two-hundred day moving average price of GBX 11.62.

Insider Buying and Selling at C4X Discovery

In other C4X Discovery news, insider Clive Dix purchased 485,320 shares of the firm’s stock in a transaction that occurred on Monday, April 8th. The shares were bought at an average price of GBX 10 ($0.13) per share, with a total value of £48,532 ($61,386.29). 27.13% of the stock is currently owned by company insiders.

About C4X Discovery

(Get Free Report)

C4X Discovery Holdings plc operates as drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules.

Featured Articles

Receive News & Ratings for C4X Discovery Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C4X Discovery and related companies with MarketBeat.com's FREE daily email newsletter.